Precision BioSciences, Inc. (DTIL) vs Electra Therapeutics Inc. (ETRA)

A side-by-side comparison of Precision BioSciences, Inc. and Electra Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DTIL

Precision BioSciences, Inc.

$170M

$6.16HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

ETRA

Electra Therapeutics Inc.

$203M

$9.58HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

Total return — DTIL vs ETRA

growth of $100 · dividends reinvested · last 1y

DTIL -5.4% (-5.4%/yr)ETRA -26.5% (-26.5%/yr)DTIL compounded faster over this window

DTIL ETRA

Metrics side by side

Total return (annualized)

Metric	DTIL	ETRA
Total return (1Y)	15.91%	N/A
Total return CAGR (3Y)	-12.53%	N/A
Total return CAGR (5Y)	-54.84%	N/A

ETRA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full DTIL analysis Full ETRA analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.